Literature DB >> 33061597

Preoperative Risk Classification Using Neutrophil-to-Lymphocyte Ratio and Albumin for Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy.

Zihan Zhao1, Shangxun Xie1, Baofu Feng1, Shiwei Zhang1, Yifan Sun1, Hongqian Guo1, Rong Yang1.   

Abstract

PURPOSE: To improve the preoperative prediction of the outcomes of patients diagnosed with upper tract urothelial carcinoma (UTUC) treated with radical nephroureterectomy (RNU), we explored various preoperative laboratory factors and established a prognostic risk stratification method. PATIENTS AND METHODS: We retrospectively reviewed 232 UTUC patients who underwent RNU from September 2010 to October 2019 and analyzed their comprehensive clinicopathologic data and preoperative blood-based biomarkers. Kaplan-Meier analysis, receiver-operating characteristic (ROC) curves analysis and Cox regression analysis were performed to assess the relationship between these factors and the prognosis.
RESULTS: The median follow-up and age were 24 months and 68.5 years, respectively. Preoperative elevated neutrophil-to-lymphocyte ratio (NLR > 3.44) and decreased albumin (ALB < 39.8 g/L) were negatively correlated with progression-free survival (PFS), cancer-specific survival (CSS) and overall survival (OS) in both univariate and multivariate analyses. Patients were sorted into three groups based on their NLR and ALB: the low-risk group (neither elevated NLR nor decreased ALB), intermediate-risk group (either elevated NLR or decreased ALB) and high-risk group (elevated NLR and decreased ALB). Their 5-year PFS rates were 77.8%, 52.6% and 32.3%; their 5-year CSS rates were 97.7%, 71.4% and 32.9%; and their 5-year OS rates were 92.7%, 70.4% and 29.2%, respectively (all P < 0.0001). ROC curves analysis showed that NLR plus ALB had a more accurate prognostic value (P < 0.05).
CONCLUSION: Preoperative risk classification using NLR and ALB was identified as an independent prognostic factor for patients with UTUC. The combination of NLR and ALB may help to determine the most appropriate treatment options before RNU.
© 2020 Zhao et al.

Entities:  

Keywords:  albumin; neutrophil-to-lymphocyte ratio; radical nephroureterectomy; risk classification; upper tract urothelial carcinoma

Year:  2020        PMID: 33061597      PMCID: PMC7526009          DOI: 10.2147/CMAR.S274332

Source DB:  PubMed          Journal:  Cancer Manag Res        ISSN: 1179-1322            Impact factor:   3.989


  30 in total

1.  Usefulness of the neutrophil-to-lymphocyte ratio in predicting short- and long-term mortality in breast cancer patients.

Authors:  Basem Azab; Vijaya R Bhatt; Jaya Phookan; Srujitha Murukutla; Nina Kohn; Terenig Terjanian; Warren D Widmann
Journal:  Ann Surg Oncol       Date:  2011-06-03       Impact factor: 5.344

Review 2.  Urothelial carcinoma of the upper urinary tract: surgical approach and prognostic factors.

Authors:  Richard Zigeuner; Karl Pummer
Journal:  Eur Urol       Date:  2008-01-14       Impact factor: 20.096

3.  Prognostic Value of Pretreatment Albumin-to-Globulin Ratio in Patients With Non-Muscle-Invasive Bladder Cancer.

Authors:  Naoya Niwa; Kazuhiro Matsumoto; Hiroki Ide; Hirohiko Nagata; Mototsugu Oya
Journal:  Clin Genitourin Cancer       Date:  2018-01-04       Impact factor: 2.872

4.  Prognostic serum markers in patients with high-grade upper tract urothelial carcinoma.

Authors:  Kunj R Sheth; Ahmed Q Haddad; Omotola S Ashorobi; Matthew A Meissner; Arthur I Sagalowsky; Yair Lotan; Vitaly Margulis
Journal:  Urol Oncol       Date:  2016-05-24       Impact factor: 3.498

5.  Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.

Authors:  Hang Xu; Ping Tan; Jianzhong Ai; Yu Huang; Tianhai Lin; Lu Yang; Qiang Wei
Journal:  Clin Genitourin Cancer       Date:  2018-06-14       Impact factor: 2.872

6.  Incidence of downstaging and complete remission after neoadjuvant chemotherapy for high-risk upper tract transitional cell carcinoma.

Authors:  Surena F Matin; Vitaly Margulis; Ashish Kamat; Christopher G Wood; H Barton Grossman; Gordon A Brown; Colin P N Dinney; Randall Millikan; Arlene O Siefker-Radtke
Journal:  Cancer       Date:  2010-07-01       Impact factor: 6.860

7.  Is hypoalbuminemia an independent prognostic factor in patients with gastric cancer?

Authors:  Andrew B C Crumley; Robert C Stuart; Margaret McKernan; Donald C McMillan
Journal:  World J Surg       Date:  2010-10       Impact factor: 3.352

8.  Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma.

Authors:  Sunil Saroha; Robert G Uzzo; Elizabeth R Plimack; Karen Ruth; Tahseen Al-Saleem
Journal:  J Urol       Date:  2012-10-04       Impact factor: 7.450

9.  Impact of Routine Laboratory Parameters in Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: A Long-Term Follow-Up.

Authors:  Alexander Tamalunas; Alexander Buchner; Alexander Kretschmer; Friedrich Jokisch; Gerald Schulz; Lennert Eismann; Christian G Stief; Tobias Grimm
Journal:  Urol Int       Date:  2020-02-28       Impact factor: 2.089

10.  Prognostic factors in patients with advanced cancer: a comparison of clinicopathological factors and the development of an inflammation-based prognostic system.

Authors:  Barry J Laird; Stein Kaasa; Donald C McMillan; Marie T Fallon; Marianne J Hjermstad; Peter Fayers; Pal Klepstad
Journal:  Clin Cancer Res       Date:  2013-08-12       Impact factor: 12.531

View more
  3 in total

1.  What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.

Authors:  Zhenkai Luo; Binbin Jiao; Tao Huang; Hang Zhao; Guan Zhang
Journal:  Technol Cancer Res Treat       Date:  2022 Jan-Dec

2.  Reduced Preoperative Glomerular Filtration Rate Is Associated With Adverse Postoperative Oncological Prognosis in Patients Undergoing Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Retrospective Cohort Study.

Authors:  Shijie Li; Xiaonan Chen; Jianyi Zheng; Xuefeng Liu
Journal:  Front Surg       Date:  2022-04-25

3.  Pretreatment Fibrinogen-Albumin Ratio (FAR) Associated with Treatment Response and Survival in Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line Anti-PD-1 Therapy Plus Platinum-Based Combination Chemotherapy.

Authors:  Chengliang Yuan; Meifang Huang; Huilin Wang; Wei Jiang; Cuiyun Su; Shaozhang Zhou
Journal:  Cancer Manag Res       Date:  2022-01-26       Impact factor: 3.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.